DENALI THERAPEUTICS INC's ticker is DNLI and the CUSIP is 24823R105. A total of 200 filers reported holding DENALI THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 9.23 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1,146,470 | +1002.4% | 49,760 | +1312.8% | 0.00% | – |
| Q2 2022 | $104,000 | -53.6% | 3,522 | -49.4% | 0.00% | – |
| Q1 2022 | $224,000 | -65.0% | 6,959 | -51.5% | 0.00% | -100.0% |
| Q4 2021 | $640,000 | +580.9% | 14,345 | +1102.4% | 0.00% | – |
| Q2 2021 | $94,000 | -6.9% | 1,193 | -79.3% | 0.00% | -100.0% |
| Q1 2020 | $101,000 | +197.1% | 5,756 | +161.6% | 0.00% | – |
| Q3 2019 | $34,000 | +1600.0% | 2,200 | +2100.0% | 0.00% | – |
| Q4 2018 | $2,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Crestline Management, LP | 19,462,500 | $339,037,000 | 35.95% |
| Euclidean Capital LLC | 323,749 | $27,117,000 | 5.74% |
| Flagship Pioneering Inc. | 2,730,263 | $228,687,000 | 4.16% |
| Casdin Capital, LLC | 1,310,000 | $109,726,000 | 3.25% |
| A.R.T. Advisors, LLC | 6,173 | $517,000 | 2.39% |
| MARK ASSET MANAGEMENT LP | 172,040 | $14,410,000 | 1.73% |
| Temasek Holdings (Private) Ltd | 4,410,457 | $369,420,000 | 1.59% |
| Integral Health Asset Management, LLC | 57,500 | $4,816,000 | 1.43% |
| GILDER GAGNON HOWE & CO LLC | 3,219,843 | $269,694,000 | 1.34% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 19,365 | $1,622,000 | 0.95% |